Helping to keep families healthy and free from malaria since the mid-1980s.
- From 2017 to 2021, more than 533,000 individuals who tested positive for malaria received artemisinin-based therapy, as recommended by the World Health Organization.
- From 2017 to 2021, more than 712,000 pregnant women received IPT intermittent preventative treatment under direct observation—thereby receiving protection from the dangers of malaria in pregnancy.
- In Kribi District, the percentage of malaria-related deaths decreased from 24% in 2018 to 17% in 2020.
- Project-supported community health workers reached 7,483 patients with a fever, tested 98% (7,331 cases) with rapid diagnostic tests, provided treatment to 95% (5,673/5,976 cases) of patients confirmed to have malaria, and referred 1,038 patients to a health center.
Our Work in Cameroon
Improving the Quality of Malaria Control Services in Chad and Cameroon
Malaria is the leading cause of morbidity and mortality in Chad and Cameroon, and is particularly dangerous for children and pregnant women. With support from ExxonMobil, Jhpiego is strengthening the capacity of the Chadian and Cameroonian Ministries of Health, the National Malaria Control Programs, health providers and community health volunteers to provide high-quality malaria prevention and treatment for nearly 1,180,000 people living in 11 malaria-endemic districts along ExxonMobils 1,070-kilometer pipeline. The 11 districts are Doba, Bodo, Béboto, Bébédjia, Goré, Bessao, Baibokoum, Laramanaye, Donia, Kara (in Chad), and Kribi (in Cameroon). In addition to leading the development of national-level malaria guidelines, training manuals and reference materials, Jhpiego has trained health providers, supervisors and community health volunteers to provide health services and/or health messages. These interventions have resulted in provision of lifesaving treatment to people with confirmed cased of malaria and improved coverage for intermittent preventive treatment of malaria among pregnant women.
Impact Malaria is a global project of the U.S. President’s Malaria Initiative to reduce mortality and morbidity caused by malaria. Implemented by a consortium of organizations led by PSI, the project is funded by the U.S. Agency for International Development. In close collaboration with the National Malaria Control Program, other sections of the Ministry of Health and various implementing partners, Impact Malaria is designed to improve malaria service delivery via the following objectives: 1) improve the quality of and access to malaria case management and prevention of malaria in pregnancy; 2) improve the quality of and access to other malaria drug-based approaches and provide support to pilot/scale up newer malaria drug-based approaches; and 3) provide global technical leadership, support operational research and advance program learning. In Cameroon, Impact Malaria supports PMI’s focus on expanding and improving the quality of malaria case management and prevention in 300 facilities in 18 districts in the North and Far North regions.
Reaching Impact, Saturation, and Epidemic Control (RISE)
RISE is a five-year global project funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and the U.S. Agency for International Development (USAID). RISE works with countries to achieve a shared vision of attaining and maintaining epidemic control, with stronger local partners capable of managing and achieving results through sustainable, self-reliant and resilient health systems by 2024. RISE’s contributions to this work will lead to fewer new HIV infections, decreased HIV-related morbidity and mortality, and increased quality of life for people living with HIV. With USAID PEPFAR investments, RISE supports countries to achieve and maintain epidemic control by providing strategic technical assistance and direct service delivery to improve HIV prevention, case finding, treatment programming, and viral load suppression. The primary objectives of the RISE project are to: 1) attain and maintain HIV epidemic control among at-risk adult men, women and priority populations; 2) attain and maintain HIV epidemic control among key populations; 3) strengthen health systems including improved program management, health information systems, human resources for health and financial systems to ensure attainment and maintenance of epidemic control; and 4) support the transition of direct funding and implementation to capable local partners to meet the PEPFAR goal of 70% of funding to local partners by 2020. The project is led by Jhpiego with the following partners: ICAP at Columbia University, Management Sciences for Health, Anova, BAO Systems, Johns Hopkins University Center for Public Health and Human Rights, and Mann Global Health. RISE is currently active in several countries, including Cameroon.
Technical Assistance for HIV Differentiated Service Delivery
Jhpiego has been contracted by the Global Fund to Fight AIDS, Tuberculosis and Malaria to support their country programs to leverage evidence, learning and best practices about differentiated service delivery (DSD). DSD refers to a client-centered approach that simplifies and adapts HIV service across the cascade of services to better serve individual needs and reduce unnecessary burdens on the health system. Jhpiego supports standardization of approaches and innovations, and develops country-specific technical briefs, training materials and tools that leverage the latest DSD science and best practices relevant to country contexts.